Prevalence of hepatitis C virus among out-patients of a private laboratory in Tehran

Iranian Journal of Public Health

Volumn 36, Issue 1, 2007, Pages 79-84

  Hajia, M ^a,d   Shahrokhi, N ^b,d   Amirzargar, A A ^c,d   Farzanehkhah, M ^d   Biglari, S ^d   Ghorishy, M ^d   Sarafnejad, A ^d,e  

^a Ctr of Res and Ref Lab of Iran   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Noor Clinical Laboratory   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diagnosis; HCV infection; Iran; Prevalence

Indexed keywords

EID: 33947538192     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mondelli MU, Cerino A, Cividini A (2005). Acute hepatitis C: diagnosis and management. J Hepatol. 42 Suppl (1): S108-44.
2. Hnatyszyn HJ (2005). Chronic hepatitis C genotyping: the clinical significance of determing HCV genotypes. Antivir Ther, 10(1): 1-11.
3. Thomas DL, Stuart CR, Stanley ML. Hepatitis C (2005). In Principles and Practice of Infectious Disease. Mandell GL, Benett JE, Dolin, R. Chirchil Livingstone, p.: 1950.
4. Jerome KR, Gretch DR (2004). Laboratory approaches to the diagnosis of hepatitis C virus infection. Minerva Gastroenterol Dietol, 50(1): 9-20.
5. D'Souza R, Foster GR (2004). Diagnosis and treatment of hepatitis C. J R Soc Med, 97(5): 223-25.
6. Dow BC, Buchman I, Munro H (1996). Relevance of RIBA-3 suplementary test to HCV PCR positivity and genotypes for HCV confirmation of Blood donors. J Med Virol, 49(2): 132-6.
7. Poupon R. Hepatitis C (2005). Epidemiology, Management and treatment. Bull Acad Natl Med, 189(2): 375-84.
8. Wang N, Gan XQ, Han JX (2004). Simultaneous detection of HBV and HCV by multiplex PCR normalization. World J Gastroenterol, 10(16): 2439-43.
9. Huang F, Zhao GZ, Li Y (1999). HCV genotypes in hepatitis C patients and their clinical significances. World J Gastroentrology, 5(6): 547-49.
10. Alizadeh AHM, Alavian SM, Jafari K, Yazdi N (2005). Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan- Iran. World J Gastroenterol, 11(26): 4085-89.
11. Amiri ZM, Shakib AJ, Toorchi M (2005). Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran. East Mediterr Health J, 11(3):372-76.
12. Ansar MM, Kooloobandi A (2002). Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat, 9(5): 390-92.
13. Vahdani P, Hosseini-Moghaddam SM, Gachkar L, Sharafi K (2006). Prevalence of hepatitis B, hepatitis C, human immunodeficiency virus, and syphilis among street children residing in southern Tehran Iran. Arch Iran Med, 9(2): 153-55.
14. Chandra M, Khaja MN, Farces N (2003). Prevalence, risk factors and genotype distribution of HCV and HBV infection in tribal population: a community based study in south India. Trop Gastroenterol, 24(4): 193-5.
15. Alavian M, Gholami B, Masarrat S (2002). Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. Journal of Gastroenterology and Hepatology, 17: 1092.
16. Zali MR, Noroozi A, Amirrasooli H, Darvishi M (1998). Prevalence of anti-HCV antibody and routes of hematological transmission in adiects of Ghasr proson. (in Persian). Pajouhesh, 22: 26-32.